The collaboration is funded by the Mayo Clinic Center for Individualized Medicine and led by the center’s medical director, Dr. Keith Stewart.
Under the agreement, healthy patients who participate in a Mayo Clinic research study will receive a whole-genome sequencing screening test through Veritas Genetics’ flagship product, myGenome. Mayo Clinic researchers will offer clinical feedback to the Veritas Genetics team.
Mayo Clinic, which will also become a Veritas shareholder, says it will use any revenue it receives as a result of the collaboration to support its nonprofit mission to drive healthcare.
More articles on data analytics & precision medicine:
Microsoft partners with Adaptive Biotechnologies to ‘decode’ immune systems with AI
Vanderbilt-Ingram Cancer Center enters precision medicine collaboration with Tempus
4 questions with PotentiaMetrics CEO Robert Palmer on personalized healthcare
